Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort

Gut

Volumn 55, Issue 4, 2006, Pages 536-541

  Jones, D E J ^a   Bhala, N ^a   Burt, J ^b   Goldblatt, J ^a   Prince, M ^a   Newton, J L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH CERTIFICATE; DEMOGRAPHY; DISEASE SEVERITY; FATIGUE; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHOLAGOGUES AND CHOLERETICS; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; URSODEOXYCHOLIC ACID;

EID: 33645112628     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.080317     Document Type: Article

References (44)

1. Jones DEJ. Pathogenesis of primary biliary cirrhosis. J Hepatol 2003;39:639-48.
2. Jones DEJ. Primary biliary cirrhosis. Horiz Med 2005 (in press).
3. Prince MI, James OFW, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000;32:368-73.
4. Goldblatt J, Taylor PJS, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-41.
5. Cauch-Dudek K, Abbey S, Stewart DE, et al. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
6. Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life in patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-7.
7. Younossi ZM, Kiwi ML, Boporai N, et al. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000;95:497-502.
8. Stanca CM, Bach N, Krause C, et al. Evaluation of fatigue in US patients with primary biliary cirrhosis. Am J Gastroenterol 2005;100:1104-9.
9. Poupon RE, Chretien Y, Chazouilleres O, et al. Quality of life in patients with primary biliary cirrhosis. Hepatology 2004;40:489-94.
10. Jacoby A, Rannard A, Buck D, et al Development, validation and evaluation of lhe PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 2005;54:1622-9.
11. Bjornsson E, Simren M, Olsson R, et al. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005;17:351-7.
12. Jones EA, Bergasa NV. The pathogenesis and treatment of pruritus in patients with PBC. Eur J Gastroenterol Hepatol 1999;11:623-31.
13. Jones DEJ. Complications of cholestasis. Medicine 2002;30:67-8.
14. Prince M, Mitchison H, Ashley D, et al. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multi-centre randomised placebo-controlled crossover trial. Aliment Pharmacol Therap 2003;17:137-43.
15. ter Borg PCJ, van Os E, van den Broek WW, et al. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised control trial. BMC Gastroenterol 2004;4:8-16.
16. Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997;25:492-4.
17. Swain MG, Le T. Chronic cholestasis in rats induces anhedonia and loss of social interest. Hepatology 1998;28:6-10.
18. Swain MG, Beck P, Rioux K, et al. Augmented interleukin-1 beta-induced depression of locomotor activity in cholestatic rats. Hepatology 1998;28:1561-5.
19. Forton D, Patel N, Prince M, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetization transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004;53:587-92.
20. Prince M, Chetwynd A, Newman WL, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044-51.
21. Rannard AC, Buck D, Jones DEJ, et al. Assessing quality of life in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2004;2:164-74.
22. Romani A, Bergamaschi R, Candeloro E, et al. Fatigue in multiple sclerosis: Multidimensional assessment and response to symptomatic treatment. Mult Scler 2004;10:462-8.
23. Surawy C, Roberts J, Silver A. The effect of mindfulness training on mood and measures of fatigue, activity and quality of life in patients with chronic fatigue syndromeon a hospital waiting list: A series of exploratory studies. Behav Cogn Psychother 2005;33:103-9.
24. Jones DEJ, James OFW, Bassendine MF. Primary biliary cirrhosis: Clinical and associated autoimmune features and natural history. Clin Liver Dis 1998;2:265-82.
25. Christensen E, Crowe J, Doniach D, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;78:236-46.
26. Beswick D, Klatskin G, Boyer J. Asymptomatic primary biliary cirrhosis: A progress report on long-term follow-up and natural history. Gastroenterology 1985;89:268-71.
27. Balasubramaniam K, Grambsh PM, Wiesner RH, et al. Diminished survival in asymptomatic primary biliary cirrhosis. Gastroenterology 1990;98:1707-9.
28. Prince MI, Jones DEJ. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J 2000;76:199-206.
29. Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-90.
30. Corpechot C, Carrat F, Bahr A, et al. The effect of ursodeoxycholic acid therapy on the natural history of primary biliary cirrhosis. Gastroenterology 2005;128:297-303.
31. Crippin JS, Lindor KD, Jorgenson R, et al. Hypercholesterolaemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992;15:858-62.
32. Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002;51:265-9.
33. Newton JL, Bhala N, Jones DEJ. Fatigue in primary biliary cirrhosis is associated with nocturnal hypotension. Hepatology 2004;40:461A.
34. Newton JL, Bhala N, Jones DEJ. Autonomic dysfunction is common in both cirrhotic and precirrhotic primary biliary cirrhosis. Hepatology 2004;40:466A.
35. Newton JL, Bhala N, Jones DEJ. Risk factors for sudden cardiac death in primary biliary cirrhosis. Hepatology 2004;40:462A.
36. Keresztes K, Istenes I, Folhoffer A, et al. Autonomic and sensory nerve dysfunction in primary biliary cirrhosis. World J Gastroenterol 2004;10:3030-43.
37. Parati G, Di Renzo M, Mancia G. Dynamic modulation of baroreflex sensitivity in health and disease. Ann N Y Acad Sci 2001;940:469-87.
38. Vanoli E, Cerati D, Pedretti RF. Autonomic control of heart rate: pharmacological and non-pharmacological modulation. Basic Res Cardiol 1998;93:133-42.
39. Schwarz PJ. The autonomic nervous system and sudden death. Eur Heart J 1998;19:F72-80.
40. Flackenecker P, Rufer A, Bihler I, et al. Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology 2003;61:851-3.
41. Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol 1999;246:893-8.
42. Peckerman A, La Mancha JJ, Quereshi B, et al. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome. Psychosom Med 2003;65:889-95.
43. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural tachycardia syndrome and chronic fatigue syndrome is characterised by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000;48:218-26.
44. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000;320:1-8.